FHI Clinical
is a Private company. Ted FitzGerald is the President & CEO of FHI Clinical. FHI Clinical's most recent acquisition was Triclinium Clinical Development Proprietary Limited for an undisclosed amount on Dec 2021. FHI Clinical has 3 followers on Owler.FHI Clinical
is a Private company. Ted FitzGerald is the President & CEO of FHI Clinical. FHI Clinical's most recent acquisition was Triclinium Clinical Development Proprietary Limited for an undisclosed amount on Dec 2021. FHI Clinical has 3 followers on Owler.
News
May 02, 2022
Newswire
Press Release: FHI Clinical : FHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory Therapies
Dec 15, 2021
FierceBiotech
FHI Clinical: FHI Clinical acquires South African CRO to expand global footprint
Dec 06, 2021
The Business Journals: Raleigh/Durham
FHI Clinical: Durham CRO solidifies presence in Africa with acquisition in key market
Dec 03, 2021
Citybizlist
FHI Clinical: FHI Clinical Announces Intent to Acquire Triclinium Clinical Development
Jun 24, 2021
Pharamceutical Technology
FHI Clinical: Tiziana, FHI Clinical partner for Phase II intranasal Covid-19 drug trial
Oct 19, 2020
Outsourcing-Pharma
FHI Clinical: FHI Clinical, Oracle partner on cloud-based trial tech
Oct 12, 2020
PRZOOM
Press Release: FHI Clinical : FHI Clinical and Oracle Bring Critical Clinical Trial Capabilities to Markets in Need
Jul 23, 2020
Outsourcing-Pharma
FHI Clinical: FHI Clinical to support ACTT remdesivir trial for COVID-19
Jul 14, 2020
Drug Genius
FHI Clinical: FHI Clinical Inc. Providing Clinical Operations Services for ACTT-1 Trial of Remdesivir for Treatment of COVID-19
Apr 03, 2020
MarketScreener
FHI Clinical: FHI Clinical Providing Full-Service CRO Capabilities for Coronavirus (COVID-19) Clinical Trial